<VariationArchive VariationID="2810691" VariationName="NM_000286.3(PEX12):c.611_612del (p.Thr204fs)" VariationType="Deletion" Accession="VCV002810691" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-29" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2965365" VariationID="2810691">
      <GeneList>
        <Gene Symbol="PEX12" FullName="peroxisomal biogenesis factor 12" GeneID="5193" HGNC_ID="HGNC:8854" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35574795" stop="35578571" display_start="35574795" display_stop="35578571" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33901813" stop="33905655" display_start="33901813" display_stop="33905655" Strand="-" />
          </Location>
          <OMIM>601758</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000286.3(PEX12):c.611_612del (p.Thr204fs)</Name>
      <CanonicalSPDI>NC_000017.11:35577105:TGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35577106" stop="35577107" display_start="35577106" display_stop="35577107" variantLength="2" positionVCF="35577105" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33904125" stop="33904126" display_start="33904125" display_stop="33904126" variantLength="2" positionVCF="33904124" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>T204fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.33904126_33904127del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.33904126_33904127del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.35577107_35577108del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.35577107_35577108del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008447.1" sequenceAccession="NG_008447" sequenceVersion="1" change="g.6531_6532del">
            <Expression>NG_008447.1:g.6531_6532del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000286.3" sequenceAccession="NM_000286" sequenceVersion="3" change="c.611_612del" MANESelect="true">
            <Expression>NM_000286.3:c.611_612del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000277.1" sequenceAccession="NP_000277" sequenceVersion="1" change="p.Thr204fs">
            <Expression>NP_000277.1:p.Thr204fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000286.3(PEX12):c.611_612del (p.Thr204fs) AND Peroxisome biogenesis disorder 3A (Zellweger)" Accession="RCV003649728" Version="1">
        <ClassifiedConditionList TraitSetID="8948">
          <ClassifiedCondition DB="MedGen" ID="C3553929">Peroxisome biogenesis disorder 3A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-20" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15542397</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21031596</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33123925</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17429" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)</ElementValue>
                <XRef Type="Allelic variant" ID="601758.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 3A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013927" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD3A</ElementValue>
                <XRef ID="GTR000522760" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 3 (CG3) have mutations in the PEX12 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15858" />
                <XRef ID="15858" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553929" DB="MedGen" />
              <XRef ID="MONDO:0013927" DB="MONDO" />
              <XRef Type="MIM" ID="614859" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8196377" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="17821949|MedGen:C3553929" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004406833" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15542397</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21031596</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33123925</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr204Serfs*13) in the PEX12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 156 amino acid(s) of the PEX12 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX12-related conditions. This variant disrupts a region of the PEX12 protein in which other variant(s) (p.Gln349del) have been determined to be pathogenic (PMID: 15542397, 21031596, 33123925; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.33904125_33904126del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553929" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8196377" TraitType="Disease" MappingType="XRef" MappingValue="C3553929" MappingRef="MedGen">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

